ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment 04 Jun 2023 A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study. Find out more Show/Hide
Researchers find immune system link with rare ovarian cancer that could guide future treatment 14 Oct 2021 Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found. Find out more Show/Hide
ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer 19 Sep 2021 A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more Show/Hide
ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer 18 Sep 2020
ICR calls for wider gene testing in ovarian cancer after approval of olaparib earlier in treatment for women with BRCA mutations 26 Jul 2019